학술논문
Mosunetuzumab Monotherapy is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory Follicular Lymphoma who have Received >= 2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study
Document Type
Journal
Author
Budde, Elizabeth; Sehn, Laurie H.; Matasar, Matthew; Schuster, Stephen J.; Assouline, Sarit; Giri, Pratyush; Kuruvilla, John; Canales, Miguel; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta; Wei, Michael C.; Yin, Shen; Doral, Michelle Y.; Li, Chi-Chung; Huang, Huang; Negricea, Raluca; Penuel, Elicia; O'Hear, Carol; Bartlett, Nancy L.; El-Sharkawi, Dima
Source
Subject
Language
English
ISSN
13652141